NCT06444412View on ClinicalTrials.gov

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 26, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
WHO Grade 3 GliomaWHO Grade 4 Glioma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

OTHER

Electronic Health Record Review

Ancillary studies

DRUG

Ga 68 PSMA-11

Contrast dye given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06444412 - An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma | Biotech Hunter | Biotech Hunter